查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美醫藥合約銷售組織市場預測至 2030 年 - 區域分析 - 按服務、模組、治療領域和最終用戶
市場調查報告書
商品編碼
1494468

北美醫藥合約銷售組織市場預測至 2030 年 - 區域分析 - 按服務、模組、治療領域和最終用戶

North America Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User
出版日期: | 出版商: The Insight Partners | 英文 86 Pages | 訂單完成後即時交付

價格

北美藥品合約銷售組織市場預計將從2022年的39.8729億美元成長到2030年的76.1412億美元。

數位技術的日益整合推動北美藥品合約銷售組織市場

數位技術的增加部署推動了藥品合約銷售組織 (CSO) 市場的轉型浪潮。這項根本性變化凸顯了對動態變化的醫藥市場採取戰術反應的必要性。簡化銷售營運、提高生產力以及應對日益數位化的醫療保健環境的複雜性的一個重要組成部分是將數位工具和技術整合到 CSO 中。借助先進的客戶關係管理工具、人工智慧和資料分析，CSO 可以獲得寶貴的見解、客製化銷售策略並與醫療保健專業人員建立更深層的關係。除了加快資訊傳輸之外，數位平台的無縫整合還可以即時適應市場趨勢和立法變化。製藥 CSO 領域的這種技術變革不僅僅是一種時尚，而是一種時尚。它代表了對銷售策略的製定和實施方式的根本性重新定義。數位技術的採用使公民社會組織處於創新的前沿。它促進了一個更具回應性的環境，與席捲醫療保健產業的更大的數位轉型一致。隨著製藥 CSO 繼續利用數位化的力量，在技術專業知識、戰略敏捷性和對製藥生態系統當代需求的清晰認知的推動下，市場將實現持續成長。

北美藥品合約銷售組織市場概況

北美的藥品合約銷售組織市場分為美國、加拿大和墨西哥。 2022年，美國在該地區佔據最大市場佔有率，預計在預測期內將繼續保持主導地位。由於合約銷售組織採用新技術、製藥公司日益重視促進小分子和生物製藥藥物的銷售以及對切割的關注度增加，北美的藥品合約銷售組織市場預計將成長。合約銷售組織市場成長的主要因素。隨著時間的推移，新藥的上市數量激增。根據 IQVIA 的研發趨勢報告，2021 年全球推出了 84 種新活性化合物，是前 5 年推出數量的兩倍。隨著國際藥物發布的增加，預計對合約銷售服務的需求將會增加。北美佔據藥品合約銷售組織市場的最大佔有率。 EPS Corp. 等主要參與者； IQVIA 公司；和 Axxelus 為該地區的市場提供了動力。

北美藥品合約銷售組織市場收入及 2030 年預測（百萬美元）

北美藥品合約銷售組織市場細分

北美藥品合約銷售組織市場分為服務、模組、治療領域、最終用戶和國家。

根據服務，北美藥品合約銷售組織市場分為商業服務和非商業服務。 2022年，商業服務領域在北美藥品合約銷售組織市場中佔據更大佔有率。

根據模組，北美藥品合約銷售組織市場分為聯合模組和專用模組。 2022 年，聯合模組細分市場在北美藥品合約銷售組織市場中佔據更大佔有率。

根據治療領域，北美藥品合約銷售組織市場分為心血管疾病、腫瘤、代謝性疾病、神經病學、骨科疾病、傳染病等。 2022 年，腫瘤學領域在北美藥品合約銷售組織市場中佔據最大佔有率。

根據最終用戶，北美藥品合約銷售組織市場分為生物製藥公司和製藥公司。 2022 年，製藥公司細分市場在北美藥品合約銷售組織市場中佔據更大佔有率。

根據國家/地區，北美藥品合約銷售組織市場分為美國、加拿大和墨西哥。 2022年，美國在北美藥品合約銷售組織市場佔據主導地位。

Aenova Holding GmbH、Axxelus Inc、CMIC Holdings Co Ltd、IQVIA Holdings Inc、Peak Pharma Solutions Inc、Pfizer Inc、Promoveo Health LLC、QFR Solutions LLC、Sales Focus Inc 和 Syneos Health Inc 是在北方營運的一些領先公司美國藥品合約銷售組織市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美藥品合約銷售組織市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析

第 5 章：北美藥品合約銷售組織市場 - 主要產業動態

  • 主要市場促進因素
    • 數位科技的不斷融合
    • 製藥公司對增加產品銷售的興趣日益濃厚
  • 主要市場限制
    • 與外包相關的品質問題
  • 主要市場機會
    • 遠距醫療和遠距細節的使用不斷增加
  • 未來主要趨勢
    • 新興市場的擴張
  • 影響分析：

第 6 章： 藥品合約銷售組織市場 - 北美市場分析

  • 北美藥品合約銷售組織市場收入，2022 - 2030

第 7 章：北美藥品合約銷售組織市場 - 收入和 2030 年預測 - 按服務

  • 概述
  • 2022 年及 2030 年北美藥品合約銷售組織市場收入佔有率（按服務分類）（%）
  • 商業服務
  • 非商業服務

第 8 章：北美藥品合約銷售組織市場 - 收入和 2030 年預測 - 按模組

  • 概述
  • 北美藥品合約銷售組織市場收入佔有率，按模組 2022 年和 2030 年 (%)
  • 聯合模組
  • 專用模組

第 9 章：北美藥品合約銷售組織市場 - 收入和 2030 年預測 - 按治療領域

  • 概述
  • 2022 年和 2030 年北美藥品合約銷售組織市場收入佔有率（按治療領域）（%）
  • 心血管疾病
  • 腫瘤學
  • 代謝紊亂
  • 神經病學
  • 骨科疾病
  • 傳染性疾病
  • 其他

第 10 章：北美藥品合約銷售組織市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年及 2030 年北美藥品合約銷售組織市場收入佔有率（按最終用戶分類）（%）
  • 生物製藥公司
  • 製藥公司

第 11 章：北美藥品合約銷售組織市場 - 國家分析

  • 北美洲
      • 北美藥品合約銷售組織市場（按國家/地區）
      • 美國
      • 加拿大
      • 墨西哥

第 12 章：藥品合約銷售組織市場 - 產業格局

  • 概述
  • 成長策略
    • 概述

第 13 章：公司簡介

  • CMIC Holdings Co Ltd
  • Axxelus Inc
  • IQVIA Holdings Inc
  • Peak Pharma Solutions Inc
  • QFR Solutions LLC
  • Promoveo Health LLC
  • Syneos Health Inc
  • Aenova Holding GmbH
  • Pfizer Inc
  • Sales Focus Inc

第 14 章：附錄

Product Code: BMIRE00030017

The North America pharmaceutical contract sales organizations market is expected to grow from US$ 3,987.29 million in 2022 to US$ 7,614.12 million by 2030. It is estimated to record a CAGR of 8.4% from 2022 to 2030.

Increasing Integration of Digital Technologies Drives North America Pharmaceutical Contract Sales Organizations Market

The increased deployment of digital technologies fuels a transformational surge in the pharmaceutical contract sales organization (CSO) market. This fundamental change highlights the need for a tactical response to the dynamically changing pharmaceutical market. An essential component of streamlining sales operations, increasing productivity, and navigating the complexities of a healthcare environment that is becoming increasingly digitized is integrating digital tools and technologies into CSOs. With advanced customer relationship management tools, artificial intelligence, and data analytics, CSOs can gain valuable insights, customize their sales strategies, and establish deeper relationships with healthcare professionals. In addition to speeding up information transmission, the seamless integration of digital platforms allows for real-time adaptability to market trends and legislative changes. This technological change in the pharmaceutical CSO landscape represents more than just a fad; it represents a fundamental redefining of how sales tactics are developed and implemented. The adoption of digital technologies places CSOs at the forefront of innovation. It promotes a more responsive environment that aligns with the larger digital transformation sweeping the healthcare sector. The market is positioned for sustained growth as pharmaceutical CSOs continue to use the power of digitalization, propelled by a convergence of technological expertise, strategic agility, and a clear awareness of the contemporary demands of the pharmaceutical ecosystem.

North America Pharmaceutical Contract Sales Organizations Market Overview

The pharmaceutical contract sales organizations market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The pharmaceutical contract sales organizations market in North America is expected to grow due to the adoption of new technologies by contract sales organizations, the surging emphasis of pharmaceutical companies in boosting the sales of small-molecule and biopharmaceutical drugs, and an increase in focus on cutting down the costs incurred by in-house sales operations are the major factors driving the growth of the pharmaceutical contract sales organizations market in North America. The number of launches of new medicine has spiked over time. According to a report by IQVIA on R&D trends, 84 new active compounds were introduced globally in 2021, twice as many as introduced in the previous 5 years. The demand for contract sales services is anticipated to rise with the increase in drug releases internationally. North America accounts for the largest share of the pharmaceutical contract sales organization market. Key players such as EPS Corp.; IQVIA, Inc.; and Axxelus fuel the market in this region.

North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

North America Pharmaceutical Contract Sales Organizations Market Segmentation

The North America pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the North America pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on modules, the North America pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the North America pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the North America pharmaceutical contract sales organizations market in 2022.

Based on end user, the North America pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on country, the North America pharmaceutical contract sales organizations market is segmented into the US, Canada, and Mexico. The US dominated the North America pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, and Syneos Health Inc are some of the leading companies operating in the North America pharmaceutical contract sales organizations market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Pharmaceutical Contract Sales Organizations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

5. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Integration of Digital Technologies
    • 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
  • 5.2 Key Market Restraints
    • 5.2.1 Quality Issues Associated with Outsourcing
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Use of Telemedicine and Remote Detailing
  • 5.4 Key Future Trends
    • 5.4.1 Expansion in Emerging Markets
  • 5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - North America Market Analysis

  • 6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • 7.3 Commercial Services
    • 7.3.1 Overview
    • 7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Non-Commercial Services
    • 7.4.1 Overview
    • 7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

  • 8.1 Overview
  • 8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • 8.3 Syndicated Modules
    • 8.3.1 Overview
    • 8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Dedicated Modules
    • 8.4.1 Overview
    • 8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

  • 9.1 Overview
  • 9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • 9.3 Cardiovascular Disorders
    • 9.3.1 Overview
    • 9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Oncology
    • 9.4.1 Overview
    • 9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Metabolic Disorders
    • 9.5.1 Overview
    • 9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Neurology
    • 9.6.1 Overview
    • 9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Orthopaedic Diseases
    • 9.7.1 Overview
    • 9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.8 Infectious Diseases
    • 9.8.1 Overview
    • 9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • 10.3 Biopharmaceutical Companies
    • 10.3.1 Overview
    • 10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Pharmaceutical Contract Sales Organizations Market - Country Analysis

  • 11.1 North America
      • 11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country
      • 11.1.1.2 US
        • 11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Canada
        • 11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.4 Mexico
        • 11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview

13. Company Profiles

  • 13.1 CMIC Holdings Co Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Axxelus Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 IQVIA Holdings Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Peak Pharma Solutions Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 QFR Solutions LLC
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Promoveo Health LLC
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Syneos Health Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Aenova Holding GmbH
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Pfizer Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Sales Focus Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation
  • Table 2. US: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
  • Table 15. Glossary of Terms, North America Pharmaceutical Contract Sales Organizations Market

List Of Figures

  • Figure 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • Figure 7. Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • Figure 10. Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • Figure 13. Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 21. Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. North America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)